Cheng, Na
Wang, Bingzhi
Xu, Jiaqi
Xue, Liyan
Ying, Jianming
Article History
Received: 31 October 2023
Revised: 14 January 2024
Accepted: 27 January 2024
First Online: 21 February 2024
Declarations
:
: The study was approved by the Institutional Review Board of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, and individual consent was waived for this retrospective analysis.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.